ラベル

AI Forecast 8306MUFG (214) Social (75) life (70) Financial (62) IT (57) Proposal (56) idea (50) Fund Management (48) Trading (43) economics (42) Covid-19 (40) AI (38) Hedge Fund (36) Risk (36) Culture (31) BOJ (29) Science (26) hobby (24) accounting (17) Apps (16) career (11) job (7) Travel (6) Hiking (5) emotion (5) music (3) Statarb (2) piano (2)

2020年7月9日木曜日

なぜ、日本のコロナの被害が少ないか? Why Covid-19 Mortality is Low in Japan?

なぜ、日本のコロナの被害が少ないか? Why Covid-19 Mortality is Low in Japan?


なぜ、日本などアジアの国はコロナの被害が少ないのか、世界中で不思議がられている。私もその一人だったが、今朝TV(羽鳥慎一モーニングショー 2020年7月9日)で児玉龍彦教授の学説を聞いて、多分これだろうなと思った。World wonders why damages from Covid-19 are significantly smaller in Asian countries including Japan. I was one of them but I just saw one probable reason on TV program(Shinichi Hatori Morning Show 2020Jul9) this morning where Prof. Tatsuhiko Kodama explained his finding as well as theory. 

児玉教授はIgGとIgMというコロナの抗体の感染後の血中濃度の推移を日本の感染者について調べた。通常、感染経験が無い場合、IgMが最初に、IgGが後から高くなるが、多くの日本人感染者はIgGが先に高くなり、過去の感染経験を示した。Prof. Kodama followed blood concentration transition of Covid-19 antibody IgG and IgM for Japanese patients after infection. Normally, if not infected before, IgM concentration comes first followed by IgG concentration. However, most of infected Japanese patients showed IgG hike before IgM, indicating the previous infection. 

IgMが先に高くなった人たちは重症化したが、IgGが先に高くなった人は重症化しなかった。Those who showed IgM hike earlier ended up with severe symptoms however those with higher IgG in the beginning did not get into serious condition. 

どうやら、日本人など、アジア諸国は、毎年の行事のようになったインフルエンザの攻撃により、多くの人が交差免疫を取得していたようだ。Looks like, Asian countries including Japan already got cross-immunity due to annual persistent attacks by influenza. 

ただ、現時点では、これは学説の様で、被害が大きかった欧米諸国の調査が行われないと確証は得られないだろう。また、今後を保証するものでは全くないことは言うまでもない。However at this point, this is still in the stage of one theory, since no study has been done for US and European countries that were most hard hit. Also need to note that, as TV program says, this will not guarantee anything going to happen in the future.